Anpario (LON:ANP – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Canaccord Genuity Group in a report released on Friday,Digital Look reports. They currently have a GBX 570 price objective on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 10.56% from the stock’s previous close.
Separately, Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a research report on Thursday, June 18th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Anpario presently has an average rating of “Buy” and an average target price of GBX 570.
View Our Latest Analysis on ANP
Anpario Stock Performance
Anpario announced that its Board of Directors has initiated a stock repurchase plan on Monday, April 27th that authorizes the company to buyback 0 outstanding shares. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares buyback plans are generally a sign that the company’s management believes its stock is undervalued.
Anpario Company Profile
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Read More
- Five stocks we like better than Anpario
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
- Data Center Delays Create Opportunity in These 3 Stocks
- Uncle Sam Plugs In: Nuclear Energy’s Cash Flow Moment Is Finally Here
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.
